Vantage logo

Sanofi seeks to build on COPD win

Full Dupixent data confirm the drug’s blockbuster potential in the lung disease, but the French drug maker is thinking even bigger.

Vantage logo

Sobi strikes again

CTI Biopharma sees an unlikely end to its 32-year rollercoaster existence.